Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd -

Singapore - English - HSA (Health Sciences Authority)

zimmer pte. ltd. - orthopaedics - the biomet proximal humerus plating system is indicated for fixation of fractures and fracture dislocations, fusions, osteotomies and non‐unions of the humerus, particularly in osteopenic bone.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - orthopaedics - synthes lcp periarticular proximal humerus plates 3.5 (stainless steel) are indicated for fractures, fracture dislocations, osteotomies, and non-unions of the proximal humerus, particularly in osteopenic bone.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - orthopaedics - the 3.5 mm lcp periarticular proximal humerus plate is indicated for fractures and fracture dislocations (neer type 2, 3, and 4-part fractures), osteotomies, and nonunions of the proximal humerus, particularly for patients suffering from osteoporosis.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - orthopaedics - locking compression plate (humerus, titanium) is intended for fixation of fractures, osteotomies, and non-unions of the radius/ulnar, particularly in osteopenic bone

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - isosorbide mononitrate - prolonged-release capsule - 50 milligram(s) - organic nitrates; isosorbide mononitrate

Canada - English - Health Canada

apotex inc - darifenacin (darifenacin hydrobromide) - tablet (extended-release) - 15mg - darifenacin (darifenacin hydrobromide) 15mg - antimuscarinics

Canada - English - Health Canada

apotex inc - darifenacin (darifenacin hydrobromide) - tablet (extended-release) - 7.5mg - darifenacin (darifenacin hydrobromide) 7.5mg - antimuscarinics

United States - English - NLM (National Library of Medicine)

merus labs international inc. - gemifloxacin mesylate (unii: x4s9f8rl01) (gemifloxacin - unii:okr68y0e4t) - gemifloxacin 320 mg - factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration and clinical studies. ) acute bacterial exacerbation of chronic bronchitis (abecb) caused by streptococcus pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, or moraxella catarrhalis . because fluoroquinolones, including factive, have been associated with serious adverse reactions (see warnings ) and for some patients abecb is self-limiting, reserve factive for treatment of abecb in patients who have no alternative treatment options. community-acquired pneumonia (of mild to moderate severity) caused by streptococcus pneumoniae (including multi-drug resistant strains [mdrsp])*, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydia pneumoniae, or klebsiella pneumoniae . *mdrsp: multi-drug resistant s

Malta - English - Medicines Authority

merus labs luxco s.à r.l. - isosorbide dinitrate - concentrate for solution for infusion or injection - isosorbide dinitrate 1 milligram(s)/millilitre - cardiac therapy